Application of human papillomavirus in screening for cervical cancer and precancerous lesions

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 2979-2982

  Wang, Jin Liang ^a   Yang, Yi Zhuo ^a   Dong, Wei Wei ^a   Sun, Jing ^a   Tao, Hai Tao ^a   Li, Rui Xin ^a   Hu, Yi ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cervical cancer; Cervical thinprep cytology test; Colposcopy; Human papillomavirus; Screening

Indexed keywords

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CYTOLOGY; EARLY DIAGNOSIS; FEMALE; HUMAN; MASS SCREENING; METAPLASIA; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS; UTERINE CERVIX; VAGINA SMEAR; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; CYTOLOGICAL TECHNIQUES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; METAPLASIA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS; VAGINAL SMEARS;

EID: 84880376916     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.2979     Document Type: Article

References (26)

1. Balbi G, Napolitano A, Giordano F, et al (2012). Role of the association of high-risk HPV identified by real-time PCR in cervical preneoplastic lesions. Eur J Gynaecol Oncol, 33, 467-71.
2. Berois N, De Cremoux P, Mazal D, et al (2013). Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay. Int J Gynecol Cancer, 23, 527-32.
3. Bolgova LS, Tuganova TN, Alekseenko OI (2012). The cytological diagnostics of dysplasia and epidermoid carcinoma of the cervix in studying the nucleolar-organizing regions of chromosomes. Klin Lab Diagn, 11, 36-41.
4. Canadian Task Force on Preventive Health Care, Pollock S, Dunfield L, et al (2013). Recommendations on screening for cervical cancer. CMAJ, 185, 35-45.
5. Corcoran J, Dattalo P, Crowley M (2012). Cervical cancer screening interventions for U.S. Latinas: a systematic review. Health Soc Work, 37, 197-205.
6. Croswell J, Costello A (2012). Screening for cervical cancer. Am Fam Physician, 86, 563-4.
7. Ding L, Zou XJ, Ao JE, et al (2008). ELISA test to detect CDKN2A (p16(INK4a)) expression in exfoliative cells: a new screening tool for cervical cancer. Mol Diagn Ther, 12, 395-400.
8. Dollin J (2013). Preventing cervical cancer: beyond following guidelines. CMAJ, 185, 13-4.
9. Galarowicz B, Jach R, Kidzierska J, et al (2012). The role of mRNA E6/E7 HPV high oncogenic risk expression in colposcopy of cervical intraepithelial neoplasia (CIN). Przegl Lek, 69, 651-7.
10. Gerli S, Bavetta F, Di Renzo GC (2012). Antisepsis regimen in the surgical treatment of HPV generated cervical lesions: polyhexamethylene biguanide vs chlorhexidine. A randomized, double blind study. Eur Rev Med Pharmacol Sci, 16, 1994-8.
11. Giraldi G, De Luca d'Alessandro E (2012). The HPV infection in males: an update. Ann Ig, 24, 497-506.
12. Jablonowska D, Marszalek A, Bodnar M (2012). Tabacco smoking, HPV infection and changes in cervix. Przegl Lek, 69, 740-3.
13. Jach R, Posadzka E, Sliwinska A, et al (2012). The influence of surgery of cervical intraepithelial neoplasia (CIN) and cervical carcinoma on quality of life. Przegl Lek, 69, 647-50.
14. Konno R (2013). Screening of uterine cervical neoplasms and HPV vaccine. Gan To Kagaku Ryoho, 40, 165-9.
15. Li J, Kang LN, Qiao YL (2011). Review of the cervical cancer disease burden in mainland China. Asian Pac J Cancer Prev, 12, 1149-53.
16. Li RF, Gupta M, McCluggage WG, et al (2013). Embryonal rhabdomyosarcoma (botryoid type) of the uterine corpus and cervix in adult women: report of a case series and review of the literature. Am J Surg Pathol, 37, 344-55.
17. McCann GA, Boutsicaris CE, Preston MM, et al (2013). Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage disease. Gynecol Oncol, 129, 135-9.
18. Ohta Y, Kunimura T, Omatsu M, et al (2013). Mixed mucinproducing and squamous differentiated tumor of the uterine cervix: a report of a case as adenosquamous carcinoma in situ. J Obstet Gynaecol Res, 39, 420-3.
19. Piura E, Piura B (2012). Brain metastases from cervical carcinoma: overview of pertinent literature. Eur J Gynaecol Oncol, 33, 567-73.
20. Pruski D, Fraszczak J, Iwaniec K, et al (2012). Assessment of frequency of regression and progression of mild cervical neoplasia-LGSIL in women with positive high-risk HPV DNA test result. Ginekol Pol, 83, 572-5.
21. Rai B, Patel FD, Chakraborty S, et al (2013). Bladder-rectum spacer balloon in high-dose-rate brachytherapy in cervix carcinoma. Int J Radiat Oncol Biol Phys, 85, e217-22.
22. Salehi M, Taheri T, Mohit E, et al (2012). Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model. Immunotherapy, 4, 1107-20.
23. Singhal P, Hussain S, Thakur N, et al (2013). Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma. DNA Cell Biol, 32, 19-27.
24. Xue Y, An R, Zhang D, et al (2011). Detection of survivin expression in cervical cancer cells using molecular beacon imaging: new strategy for the diagnosis of cervical cancer. Eur J Obstet Gynecol Reprod Biol, 159, 204-8.
25. Zeng XT, Xiong PA, Wang F, et al (2012). Passive smoking and cervical cancer risk: a meta-analysis based on 3,230 cases and 2,982 controls. Asian Pac J Cancer Prev, 13, 2687-93.
26. Zhao FH, Tiggelaar SM, Hu SY, et al (2012). A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China. Asian Pac J Cancer Prev, 13, 2369-78.